Mark For: WHISPERJECT® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 87553317 |
Registration Number | 5396475 |
Mark Literal Elements | WHISPERJECT |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2018-02-06 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Law Office Assigned | L10 |
Employee Name | LORENZO, GEORGE M |
2017-08-02 | Application Filed |
2017-10-05 | Date of First Use |
2017-10-05 | Date of Use In Commerce |
2017-11-21 | Published |
2017-11-21 | Published for Opposition |
2018-02-06 | Location: PUBLICATION AND ISSUE SECTION |
2018-02-06 | Status: Live/Registered |
2018-02-06 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2018-02-06 | Trademark Registered |
2018-07-08 | Transaction Date |
2024-02-06 | Maintenance On Time Date |
2024-08-06 | Maintenance Late Fee Date |
Party: | Mylan Pharmaceuticals, Inc. |
Address | 3711 Collins Ferry Road Morgantown, WEST VIRGINIA UNITED STATES 26505 |
Legal Entity Type | Corporation |
Legal Entity State | WEST VIRGINIA |
Drawing | 2017-08-02 | |
TEAS RF New Application | 2017-08-02 | |
Amendment to Allege Use | 2017-10-05 | |
Specimen | 2017-10-05 | |
AAU Processing Complete | 2017-10-07 | |
XSearch Search Summary | 2017-10-17 | |
Notice of Acceptance of AAU | 2017-10-18 | |
TRAM Snapshot of App at Pub for Oppostn | 2017-10-18 | |
Notice of Publication | 2017-11-01 | |
Notification Of Notice of Publication | 2017-11-01 | |
OG Publication Confirmation | 2017-11-21 | |
Registration Certificate | 2018-02-06 | |
Change Address or Representation Form | 2021-11-18 | |
Courtesy E-Reminder of Sec. 8 (6-yr) | 2023-02-06 | |
Section 8 and 15 | 2023-02-08 | |
Specimen | 2023-02-08 |
IC 005. US 006 018 044 046 051 052. G & S: Injectable pharmaceuticals for treatment of multiple sclerosis; Syringes sold filled with injectable pharmaceuticals for treatment of multiple sclerosis. FIRST USE: 20171005. FIRST USE IN COMMERCE: 20171005
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Injectable pharmaceuticals for treatment of multiple sclerosis; Syringes sold filled with injectable pharmaceuticals for treatment of multiple sclerosis |
Description | Date | Proceeding Number |
---|---|---|
TEAS SECTION 8 & 15 RECEIVED | 2023-02-08 | |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-02-06 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-11-18 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-11-18 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-11-18 | 88888 |
REGISTERED-PRINCIPAL REGISTER | 2018-02-06 | |
PUBLISHED FOR OPPOSITION | 2017-11-21 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-11-21 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-11-01 | |
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | 2017-10-18 | |
USE AMENDMENT ACCEPTED | 2017-10-17 | 73359 |
ASSIGNED TO EXAMINER | 2017-10-17 | 73359 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-17 | |
USE AMENDMENT FILED | 2017-10-06 | 88889 |
AMENDMENT TO USE PROCESSING COMPLETE | 2017-10-06 | 88889 |
TEAS AMENDMENT OF USE RECEIVED | 2017-10-05 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2017-08-08 | |
NEW APPLICATION ENTERED | 2017-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.